Home - Products - Others - Other Targets - [D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide

[D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide

CAS No. ———

[D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide( ——— )

Catalog No. M40960 CAS No. ———

[D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide
  • Description
    [D-Ala2,Met5]- β-Casomorphin (1-5) , bovine ,amide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    626.78
  • Molecular Formula
    C31H42N6O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CFT7455

    CFT7455 is an anti-cancer agent showing high affinity to the cereblon E3 ligase with a Kd of 0.9 nM. CFT7455 is an orally active degrader of zinc finger transcription factors Ikaros (IKZF1), and Aiolos (IKZF3).

  • GW-870086

    GW-870086 is an effective anti-inflammatory agent. GW-870086 also plays a role in a glucocorticoid receptor agonist (pIC50: 10.1 in A549 cells expressing NF-κB).

  • Siplizumab

    Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.